TrialBritish journal of clinical pharmacology2016

Population pharmacokinetic analysis of sifalimumab from a clinical phase IIb trial in systemic lupus erythematosus patients.

Bo Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.